EGFR inhibitor-driven endoplasmic reticulum stress-mediated injury on intestinal epithelial cells

作者: Shaocheng Hong , Yanhong Gu , Zhenzhen Gao , Lele Guo , Wenjie Guo

DOI: 10.1016/J.LFS.2014.10.008

关键词: Cell cycleEGFR inhibitorsUnfolded protein responseGefitinibProinflammatory cytokineEndoplasmic reticulumIcotinibCell growthPharmacologyMedicine

摘要: Abstract Aims The aim of this study is to understand the underlying mechanisms regulating adverse effect diarrhea caused by epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). Main methods We comparatively examined effects two EGFR-TKIs, gefitinib and icotinib, on intestinal epithelial cells (IEC-6). Cell proliferation was measured using MTT analysis. Expression multiple cytokines assayed real-time PCR. cycle apoptosis IEC were evaluated flow cytometry. Protein levels determined Western blot. Key findings These EGFR-TKIs exerted cytotoxicity inhibit induce in IEC-6 cells. are due ability these cause cell arrest at G0/G1 expression cyclin D1 p27. In addition, icotinib significantly suppressed adhesion molecules while increasing proinflammatory interleukin (IL)-6 IL-25. Finally, triggered an endoplasmic reticulum (ER) stress response, characterized activation RNA dependent protein kinase-like ER (PERK) pathway transcriptional induction XBP-1 signaling, resulting ER-mediated death. Moreover, more than Significance Because a common event occurring patients receiving small-molecular EGFR-TKI chemotherapy, results clinically significant. finding that exerts less cytotoxic activity indicates its usefulness as toxic treatment option for non-small-cell lung cancer.

参考文章(27)
Steven Kornblau, Al B. Benson, Robert Catalano, Richard E. Champlin, Constance Engelking, Michael Field, Cindy Ippoliti, Hillard M. Lazarus, Edith Mitchell, Joseph Rubin, Patrick J. Stiff, Everett Vokes, Scott Wadler, Management of Cancer Treatment–Related Diarrhea: Issues and Therapeutic Strategies Journal of Pain and Symptom Management. ,vol. 19, pp. 118- 129 ,(2000) , 10.1016/S0885-3924(99)00149-9
A P N Majumdar, Regulation of gastrointestinal mucosal growth during aging. Journal of Physiology and Pharmacology. ,vol. 54, pp. 143- 154 ,(2003)
Wenhua Liang, Xuan Wu, Wenfeng Fang, Yuanyuan Zhao, Yunpeng Yang, Zhihuang Hu, Cong Xue, Jing Zhang, Jianwei Zhang, Yuxiang Ma, Ting Zhou, Yue Yan, Xue Hou, Tao Qin, Xiaoxiao Dinglin, Ying Tian, Peiyu Huang, Yan Huang, Hongyun Zhao, Li Zhang, Network Meta-Analysis of Erlotinib, Gefitinib, Afatinib and Icotinib in Patients with Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations PLOS ONE. ,vol. 9, ,(2014) , 10.1371/JOURNAL.PONE.0085245
Li-Li Feng, Xue-Feng Wu, Hai-Liang Liu, Wen-Jie Guo, Qiong Luo, Fei-Fei Tao, Hui-Ming Ge, Yan Shen, Ren-Xiang Tan, Qiang Xu, Yang Sun, Vaticaffinol, a resveratrol tetramer, exerts more preferable immunosuppressive activity than its precursor in vitro and in vivo through multiple aspects against activated T lymphocytes Toxicology and Applied Pharmacology. ,vol. 267, pp. 167- 173 ,(2013) , 10.1016/J.TAAP.2012.12.017
Nathan I. Cherny, Evaluation and Management of Treatment-Related Diarrhea in Patients with Advanced Cancer: A Review Journal of Pain and Symptom Management. ,vol. 36, pp. 413- 423 ,(2008) , 10.1016/J.JPAINSYMMAN.2007.10.007
Anna Shkoda, Pedro A. Ruiz, Hannelore Daniel, Sandra C. Kim, Gerhard Rogler, R. Balfour Sartor, Dirk Haller, Interleukin-10 Blocked Endoplasmic Reticulum Stress in Intestinal Epithelial Cells: Impact on Chronic Inflammation Gastroenterology. ,vol. 132, pp. 190- 207 ,(2007) , 10.1053/J.GASTRO.2006.10.030
Anne-Pascale Meert, Thierry Berghmans, Targeted therapies in non-small cell lung cancer: Which implication in routine practice Toraks Cerrahisi Bulteni. ,vol. 3, pp. 167- 172 ,(2012) , 10.5152/TCB.2012.26
S Oyadomari, M Mori, Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death & Differentiation. ,vol. 11, pp. 381- 389 ,(2004) , 10.1038/SJ.CDD.4401373
G Blackledge, S Averbuch, Gefitinib ('Iressa', ZD1839) and new epidermal growth factor receptor inhibitors. British Journal of Cancer. ,vol. 90, pp. 566- 572 ,(2004) , 10.1038/SJ.BJC.6601550
Carol S Viele, Overview of chemotherapy-induced diarrhea. Seminars in Oncology Nursing. ,vol. 19, pp. 2- 5 ,(2003) , 10.1053/J.SONCN.2003.09.007